23 results on '"Ding, Guoshan"'
Search Results
2. A bioengineered drug-Eluting scaffold accelerated cutaneous wound healing In diabetic mice
3. Influence of Three-Dimensional Visual Reconstruction Technology Combined with Virtual Surgical Planning of CTA Images on Precise Resection of Liver Cancer in Hepatobiliary Surgery
4. A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective
5. Effect of adoptive reinfusion of Treg on immune rejection of islet allografts in mice
6. Prognostic model for patients receiving arterial-embolization for hepatocellular carcinoma: issues to consider
7. Hepatic Ischemia-reperfusion Injury in Mice was Alleviated by Rac1 Inhibition – More Than Just ROS-inhibition
8. An armored GPC3-directed CAR-T for refractory or relapsed hepatocellular carcinoma in China: A phase I trial.
9. Risk of adverse events in advanced hepatocellular carcinoma with immune checkpoint therapy: A systematic review and meta-analysis
10. Inhibition of miR-93 promotes interferon effector signaling to suppress influenza A infection by upregulating JAK1
11. microRNA-29a regulates liver tumor-initiating cells expansion via Bcl-2 pathway
12. Inhibition of allogeneic islet graft rejection by VISTA-conjugated liposome
13. Alsterpaullone induces apoptosis of HepG2 cells via a p38 mitogen‑activated protein kinase signaling pathway
14. MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID
15. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma
16. Schisantherin A protects against liver ischemia-reperfusion injury via inhibition of mitogen-activated protein kinase pathway
17. Hepatic IFIT3 predicts interferon‐α therapeutic response in patients of hepatocellular carcinoma
18. MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1
19. Alsterpaullone induces apoptosis of HepG2 cells via a p38 mitogen-activated protein kinase signaling pathway.
20. Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas
21. Prognostic model for patients receiving arterial-embolization for hepatocellular carcinoma: issues to consider
22. Non-alcoholic fatty liver disease: pathogenesis and models.
23. Hepatic Ischemia-reperfusion Injury in Mice was Alleviated by Rac1 Inhibition - More Than Just ROS-inhibition.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.